Bide Pharmatech Co. Ltd. A (688073) — Capital Reinvestment Ratio
Latest as of December 2025:
0.86x
Bide Pharmatech Co. Ltd. A (688073) has a Capital Reinvestment Ratio of 0.86x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥28.32 Million) in capital expenditures (CN¥24.28 Million). See 688073 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.86x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥28.32 Million
CNY
Capital Expenditures
CN¥24.28 Million
CNY
Data as of
Dec 2025
Most recent filing
Bide Pharmatech Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks Bide Pharmatech Co. Ltd. A's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Bide Pharmatech Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for Bide Pharmatech Co. Ltd. A from 2020 to 2025. For live market cap and broader valuation context, see 688073 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥28.32 Million | CN¥24.28 Million | ▲ +53.6% |
| 2024 | 0.56x | CN¥158.31 Million | CN¥88.35 Million | ▼ -56.6% |
| 2022 | 1.29x | CN¥29.87 Million | CN¥38.41 Million | ▼ -87.6% |
| 2020 | 10.35x | CN¥3.65 Million | CN¥37.73 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow